A Dose-Finding Study of Subcutaneous Herceptin (Trastuzumab) in Healthy Male Volunteers and Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Females
Clinical trial NCT00800436 · COMPLETED
Trial details
- NCT number
- NCT00800436
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2008-11-01
- Primary completion
- 2009-10-01
- Enrollment
- 66
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.